VRCI — Verici Dx Share News
0.000.00%
- £9.33m
- £8.11m
- $3.66m
Capital Access Window - Verici Dx PLC
Brief: Verici DX Announces Intention To Undertake Proposed Equity Fundraising
UK's Verici Dx H1 revenue dips as licensing income falls; adjusted EBITDA loss widens
Brief: Verici Dx Plc H1 Pretax Profit USD -4.03 Million
Proposed Fundraise and Capital Access Window
Half-year Report
Q4 launch of TranscripTx™ genetic test
Holding(s) in Company
Holding(s) in Company
Certified Service Provider agreement with Olink®
Holding(s) in Company
Investor presentation
Holding(s) in Company
Final results for the year ended 31 December 2025
Holding(s) in Company
Verici Dx PLC Canaccord GenuityGrp - Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company